institutional
NASDAQ · BMY
Bristol-Myers Squibb Company
Healthcare · Drug Manufacturers - General
$62.25
Down-$1.10 (-1.77%)
Updated Sep 24, 2026, 1:35 AM
SID Score
6.5/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 104.23B
- P/E ratio
- 17.28
- Dividend yield
- 3.98%
- 52-week range
- $52.06 – $68.64
- Volume
- 15.24M
- Avg. volume
- 16.54M
Price performance
BMY price history
1M range · 20 trading sessions · Daily adjusted prices
BMY closed at $62.25 after 20 trading sessions, down 8.35% for the selected period.
- Last close
- $62.25
- Period change
- -8.35%
- Period low
- $62.25
- Period high
- $68.09
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 22, 2026 | $62.73 | $63.08 | $62.03 | $62.25 | 15.24M |
| Sep 21, 2026 | $63.09 | $63.395 | $62.62 | $62.62 | 6.84M |
| Sep 18, 2026 | $62.71 | $63.065 | $62.19 | $63.06 | 36.85M |
| Sep 17, 2026 | $64.08 | $64.35 | $62.52 | $62.84 | 12.21M |
| Sep 16, 2026 | $64.07 | $64.385 | $63.22 | $63.60 | 9.45M |
| Sep 15, 2026 | $63.94 | $64.13 | $63.15 | $63.73 | 10M |
| Sep 14, 2026 | $64.59 | $65.29 | $63.91 | $64.10 | 6.9M |
| Sep 11, 2026 | $64.15 | $64.20 | $63.27 | $63.64 | 7.06M |
| Sep 10, 2026 | $64.92 | $64.92 | $63.73 | $63.75 | 6.5M |
| Sep 9, 2026 | $64.57 | $65.05 | $64.2608 | $64.41 | 6.57M |
| Sep 8, 2026 | $65.66 | $65.8931 | $64.395 | $64.69 | 9.52M |
| Sep 4, 2026 | $67.24 | $67.72 | $66.575 | $66.82 | 4.83M |
| Sep 3, 2026 | $68.08 | $68.24 | $66.615 | $68.09 | 6.22M |
| Sep 2, 2026 | $66.815 | $67.73 | $66.7501 | $67.66 | 7.83M |
| Sep 1, 2026 | $67.58 | $68.04 | $66.645 | $66.92 | 6.93M |
| Aug 31, 2026 | $66.25 | $67.199 | $65.9102 | $66.81 | 12.68M |
| Aug 28, 2026 | $66.77 | $66.84 | $66.19 | $66.58 | 5.54M |
| Aug 27, 2026 | $66.59 | $67.47 | $66.20 | $66.95 | 4.67M |
| Aug 26, 2026 | $67.735 | $68.00 | $67.32 | $67.57 | 7.51M |
| Aug 25, 2026 | $66.42 | $68.05 | $66.42 | $67.92 | 7.91M |
Latest BMY news
The latest Smart Investors Daily articles mentioning BMY.
Stock researchResearch & News · Analysis
Loading stock research…